Vertex Pharmaceutic(VRTX-Q)NASDAQ
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Current Target Price
High Target Price
Mean Target Price
Low Target Price
Median Target Price
Earnings Estimates
| Current Qtr12/2024 | Next Qtr03/2025 | Fiscal Yr12/2024 | Fiscal Yr12/2025 | |
|---|---|---|---|---|
| Average Estimate | 3.69 | 4.12 | -2.04 | 16.25 |
| Number of Estimates | 12 | 4 | 9 | 11 |
| High Estimate | 4.33 | 4.81 | -1.56 | 19.77 |
| Low Estimate | 3.21 | 3.85 | -2.31 | 13.86 |
| Prior Year | 3.57 | 4.29 | 13.80 | -2.04 |
| Growth Rate Est. (year over year) | +3.36% | -3.96% | -114.78% | +896.57% |
Earnings History - Surprises*
| Qtr Ending09/2024 | Qtr Ending06/2024 | Qtr Ending03/2024 | Qtr Ending12/2023 | |
|---|---|---|---|---|
| Reported | $4.04 | $-13.27 | $4.29 | $3.57 |
| Estimate | $3.61 | $-12.54 | $3.66 | $3.87 |
| Difference | +0.43 | -0.73 | +0.63 | -0.30 |
| Surprise | +11.91% | -5.82% | +17.21% | -7.75% |
* Earnings are based on GAAP income from continuing operations.
Average Analyst Ratings
Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
4.10
3 Mths Ago29
4.10
2 Mths Ago29
4.10
1 Mth Ago29
4.06
Current32
Ratings Values:
Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1
Ratings Breakdown
| 3 Mths Ago | 2 Mths Ago | 1 Mth Ago | Current | |
|---|---|---|---|---|
| # of Analysts: | 29 | 29 | 29 | 32 |
18 | 18 | 18 | 19 | |
| Holds | 9 | 9 | 9 | 11 |
2 | 2 | 2 | 2 |
Key:
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell